Harbor Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$961K Buy
22,527
+48
+0.2% +$2.61K 0.07% 374
2026
Q1
$1.41M Buy
22,479
+938
+4% +$75K 0.11% 258
2025
Q4
$2.05M Sell
21,541
-31
-0.1% -$3.04K 0.16% 166
2025
Q3
$2.11M Buy
21,572
+117
+0.5% +$12.1K 0.16% 165
2025
Q2
$2.3M Sell
21,455
-125
-0.6% -$12.6K 0.1% 270
2025
Q1
$2.18M Sell
21,580
-25,443
-54% -$2.56M 0.1% 271
2024
Q4
$4.2M Buy
47,023
+1,153
+3% +$101K 0.18% 164
2024
Q3
$3.84M Buy
45,870
+214
+0.5% +$16.9K 0.17% 178
2024
Q2
$3.52M Buy
45,656
+94
+0.2% +$6.88K 0.27% 96
2024
Q1
$3.12M Sell
45,562
-4,435
-9% -$285K 0.41% 34
2023
Q4
$2.89M Sell
49,997
-27
-0.1% -$1.44K 0.56% 29
2023
Q3
$2.64M Buy
50,024
+409
+0.8% +$21.4K 0.56% 33
2023
Q2
$2.68M Sell
49,615
-651
-1% -$34K 0.54% 34
2023
Q1
$2.51M Buy
50,266
+48,372
+2,554% +$2.28M 0.73% 39
2022
Q4
$87.6K Sell
1,894
-295
-13% -$12.8K 0.09% 93
2022
Q3
$85K Sell
2,189
-1,711
-44% -$68.6K 0.08% 91
2022
Q2
$145K Buy
3,900
+46
+1% +$1.87K 0.11% 121
2022
Q1
$171K Buy
+3,854
New +$167K 0.08% 109

Other funds holding BSX

Harbor Capital Advisors's BSX Position: Q2 2026 in Review

Harbor Capital Advisors increased its Boston Scientific (BSX) stake by 0.21% in Q2 2026, buying an estimated $2.61K and bringing the position to 22,527 shares worth $961K. The position accounts for 0.07% of the portfolio, ranked #374.

Harbor Capital Advisors first reported a position in BSX in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.2M in Q4 2024. 930 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Harbor Capital Advisors held 22,527 shares of Boston Scientific worth $961K as of Q2 2026.
  • Harbor Capital Advisors bought 48 Boston Scientific shares in Q2 2026, an estimated $2.61K.
  • Boston Scientific made up 0.07% of Harbor Capital Advisors's portfolio in Q2 2026, its #374 holding.
  • Harbor Capital Advisors first reported a position in Boston Scientific in Q1 2022 and has held it in 18 quarters since.
  • Harbor Capital Advisors's Boston Scientific position peaked at $4.2M in Q4 2024.
  • 930 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.